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Background: Previous studies have not addressed vessel response more than 5 mm distal to the stent edge. Therefore, we investigated the impact 
of paclitaxel-eluting stents (PES) compared with bare metal stents (BMS) on distal vessels in the serial intravascular ultrasound (IVUS) substudies of 
TAXUS IV, V, and VI.
Methods: TAXUS IV, V, and VI were double-blind, randomized, multicenter, controlled trials comparing PES with BMS. In their IVUS substudies 103 
patients (54 BMS, 49 PES) had IVUS data ≥10 mm distal to the stent both post-procedure and at 9 months of follow-up.
Results: Baseline characteristics were similar between the two groups. The PES group had less lumen reduction and positive vascular remodeling 
while the BMS group had lumen reduction with negative vascular remodeling at 5-10 mm distal to the stent (p=0.022, p=0.028) and at 10-15 
mm distal to the stent (p=0.055, p=0.015). However, the PES group had significant plaque increase at 5-10 mm distal to the stent (p=0.019) and 
at 10-15 mm distal to the stent (p=0.034), whereas little plaque increase was detected with BMS (p=0.40, p=0.57). These vessel responses were 
statistically consistent among 0-5 mm vs. 5-10 mm vs. 10-15 mm in both groups.
Conclusions: The use of PES was associated with significant plaque increase from baseline to 9 months’ follow-up >5 mm distal to the stent along 
with positive remodeling. Significant negative remodeling and no plaque increase were observed in BMS. These vessel responses were consistent in 
0-15 mm long distal segment.
 
